Intraventricular hemorrhage (IVH) is the most common form of cerebral hemorrhage in preterm infants, affecting ∼15–20% (1). Despite accurate postnatal monitoring, IVH is difficult to diagnose during the first 72 h after birth because at this stage, clinical symptoms and radiologic assessment of brain damage may still be silent (2). The availability in these patients of quantitative indicators suggesting subclinical lesions at a time when the monitoring indicators are unable to detect bleeding is therefore important. Furthermore, quantification of the extent of the hemorrhaged lesion could permit the prevention and/or treatment of clinical neurologic damage. S100B is an acidic calcium-binding protein found in the nervous system, where it is concentrated in glial cells (3). The presence of increased S100B in the blood and cerebrospinal fluid (CSF) is a consolidated marker of brain damage in adults and children (4)(5)(6)(7)(8) and has been proposed recently for use in preterm newborns developing IVH (9). We have detected the S100B protein in the urine of preterm newborns under normal conditions and established reference values for the protein at the first urination (10). The present work, extending from the earlier study, investigates urine S100B in preterm newborns developing IVH to offer an indicator for the early detection of IVH.
No takes yet. Share an insight, caveat, or question.
Gazzolo et al. (2001) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: